Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether nonsteroidal antiinflammatory drug
lornoxicam in combination with low dose aspirin (100mg/day) is effective and safe in patients
with Acute Coronary Syndrome without persistent ST-segment elevation.
Phase:
Phase 4
Details
Lead Sponsor:
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation Central Clinical Hospital with Outpatient Health Center of Business Administration for the President of Russian Federati